NYSE:IQV - New York Stock Exchange, Inc. - US46266C1053 - Common Stock - Currency: USD
NYSE:IQV (2/21/2025, 1:23:43 PM)
192.11
-1.9 (-0.98%)
The current stock price of IQV is 192.11 USD. In the past month the price decreased by -5.55%. In the past year, price decreased by -21.54%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TMO | THERMO FISHER SCIENTIFIC INC | 24.48 | 204.71B | ||
DHR | DANAHER CORP | 28.28 | 152.31B | ||
A | AGILENT TECHNOLOGIES INC | 25.72 | 38.82B | ||
MTD | METTLER-TOLEDO INTERNATIONAL | 31.28 | 26.93B | ||
WAT | WATERS CORP | 31.64 | 22.30B | ||
ICLR | ICON PLC | 14.52 | 16.79B | ||
WST | WEST PHARMACEUTICAL SERVICES | 31.05 | 15.18B | ||
ILMN | ILLUMINA INC | 38.68 | 15.03B | ||
RVTY | REVVITY INC | 23.16 | 13.81B | ||
AVTR | AVANTOR INC | 17.33 | 11.80B | ||
TEM | TEMPUS AI INC | N/A | 11.04B | ||
MEDP | MEDPACE HOLDINGS INC | 26.99 | 10.39B |
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 88,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.
IQVIA HOLDINGS INC
2400 Ellis Road
Durham NORTH CAROLINA 27703 US
CEO: Ari Bousbib
Employees: 88000
Company Website: https://ir.iqvia.com/
Investor Relations: https://ir.iqvia.com
Phone: 19199982000
The current stock price of IQV is 192.11 USD. The price decreased by -0.98% in the last trading session.
The exchange symbol of IQVIA HOLDINGS INC is IQV and it is listed on the New York Stock Exchange, Inc. exchange.
IQV stock is listed on the New York Stock Exchange, Inc. exchange.
31 analysts have analysed IQV and the average price target is 253.18 USD. This implies a price increase of 31.79% is expected in the next year compared to the current price of 192.11. Check the IQVIA HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
IQVIA HOLDINGS INC (IQV) has a market capitalization of 33.83B USD. This makes IQV a Large Cap stock.
IQVIA HOLDINGS INC (IQV) currently has 88000 employees.
IQVIA HOLDINGS INC (IQV) has a support level at 192.67 and a resistance level at 199.69. Check the full technical report for a detailed analysis of IQV support and resistance levels.
The Revenue of IQVIA HOLDINGS INC (IQV) is expected to grow by 4.31% in the next year. Check the estimates tab for more information on the IQV EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IQV does not pay a dividend.
IQVIA HOLDINGS INC (IQV) will report earnings on 2025-04-30, before the market open.
The PE ratio for IQVIA HOLDINGS INC (IQV) is 17.25. This is based on the reported non-GAAP earnings per share of 11.14 and the current share price of 192.11 USD. Check the full fundamental report for a full analysis of the valuation metrics for IQV.
The outstanding short interest for IQVIA HOLDINGS INC (IQV) is 1.68% of its float. Check the ownership tab for more information on the IQV short interest.
ChartMill assigns a fundamental rating of 4 / 10 to IQV. IQV has an excellent profitability rating, but there are concerns on its financial health.
Over the last trailing twelve months IQV reported a non-GAAP Earnings per Share(EPS) of 11.14. The EPS increased by 9.11% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 9.17% | ||
ROA | 5.17% | ||
ROE | 20.17% | ||
Debt/Equity | 1.76 |
ChartMill assigns a Buy % Consensus number of 81% to IQV. The Buy consensus is the average rating of analysts ratings from 31 analysts.
For the next year, analysts expect an EPS growth of 7.7% and a revenue growth 4.31% for IQV